BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Policy

  Cerus Corporation Submits The Medical Device License Application To Health Canada For INTERCEPT Plasma

  April 7, 2014

   · 

  1 min read
• Policy

  Gilead Sciences, Inc.'s Ledipasvir/Sofosbuvir Fixed-Dose Combo Hep C Tablet Wins FDA Priority Review

  April 7, 2014

   · 

  3 min read
• BioMidwest

  Nanosphere, Inc. Clarifies Recent Transactions In Company’s Common Stock

  April 7, 2014

   · 

  1 min read
• Pharm Country

  Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe

  April 7, 2014

   · 

  1 min read
• Drug Development

  Data From Intercept Pharmaceuticals’s Pivotal Phase 3 POISE Trial Of Its FXR Agonist Obeticholic Acid To Treat Primary Biliary Cirrhosis And Other Key Obeticholic Acid Data To Be Presented At EASL 2014

  April 7, 2014

   · 

  1 min read
• Biotech Bay

  Achaogen To Present At 13th Annual Needham Healthcare Conference

  April 7, 2014

   · 

  1 min read
• Deals

  Varian Medical Systems Completes Acquisition of Velocity Software Platform

  April 7, 2014

   · 

  2 min read
• Drug Development

  H. Lundbeck A/S Release: Treatment With Once-Monthly Abilify Maintena® (Aripiprazole) Significantly Reduces Hospitalisation Rates For Patients With Schizophrenia Compared With Daily Oral Antipsychotics

  April 7, 2014

   · 

  1 min read
• Business

  DBV Technologies Announces Creation Of US Subsidiary And Appoints Ms. Susanna Mesa As Vice President Of Finance, U.S. Investor Relations & Strategy

  April 7, 2014

   · 

  1 min read
• Policy

  Nexcyon Achieves European Regulatory Decision

  April 7, 2014

   · 

  3 min read